Health, social, and economic consequences of narcolepsy: A controlled national study evaluating the societal effect on patients and their partners

Sleep Medicine

Volumn 13, Issue 8, 2012, Pages 1086-1093

  Jennum, Poul ^a   Ibsen, Rikke ^b   Petersen, Eva Rosa ^a   Knudsen, Stine ^a   Kjellberg, Jakob ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Itracks   (Denmark)

^c Dansk Sundhedsinstitut   (Denmark)

Author keywords

Economic burden; Employment; Illness and health costs; Narcolepsy; Partner

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DELAYED DIAGNOSIS; DENMARK; DRUG USE; EMPLOYMENT STATUS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NARCOLEPSY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH INSURANCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOCIAL SECURITY; SOCIOECONOMICS;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COST OF ILLNESS; DENMARK; EMPLOYMENT; FEMALE; HEALTH EXPENDITURES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NARCOLEPSY; REGISTRIES; SOCIAL BEHAVIOR; SOCIAL SECURITY; SOCIOECONOMIC FACTORS; SPOUSES; YOUNG ADULT;

EID: 84865285099     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.06.006     Document Type: Article

References (33)

1. Ferri R., Miano S., Bruni O., Vankova J., Nevsimalova S., Vandi S., et al. NREM sleep alterations in narcolepsy/cataplexy. Clin Neurophysiol 2005, 116(11):2675-2684.
2. Knudsen S., Gammeltoft S., Jennum P.J. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain 2010, 133(Pt 2):568-579.
3. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000, 6(9):991-997.
4. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27(3):469-474.
5. Mignot E., Lammers G.J., Ripley B., Okun M., Nevsimalova S., Overeem S., et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002, 59(10):1553-1562.
6. Knudsen S., Jennum P.J., Alving J., Sheikh S.P., Gammeltoft S. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Sleep 2010, 33(2):169-176.
7. Kornum B.R., Kawashima M., Faraco J., Lin L., Rico T.J., Hesselson S., et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011, 43(1):66-71.
8. Hor H., Kutalik Z., Dauvilliers Y., Valsesia A., Lammers G.J., Donjacour C.E., et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010, 42(9):786-789.
9. Beusterien K.M., Rogers A.E., Walsleben J.A., Emsellem H.A., Reblando J.A., Wang L., et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999, 22(6):757-765.
10. Jennum P., Knudsen S., Kjellberg J. The economic consequences of narcolepsy. J Clin Sleep Med 2009, 5(3):240-245.
11. Dodel R., Peter H., Walbert T., Spottke A., Noelker C., Berger K., et al. The socioeconomic impact of narcolepsy. Sleep 2004, 27(6):1123-1128.
12. Broughton W.A., Broughton R.J. Psychosocial impact of narcolepsy. Sleep 1994, 17(8 Suppl.):S45-S49.
13. Broughton R., Ghanem Q., Hishikawa Y., Sugita Y., Nevsimalova S., Roth R. Socioeconomic consequences of narcolepsy. Comparative study of 3 populations in various countries. Cesk Neurol Neurochir 1987, 50(1):42-46.
14. Broughton R.J., Guberman A., Roberts J. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study. Epilepsia 1984, 25(4):423-433.
15. Kryger M.H., Walid R., Manfreda J. Diagnoses received by narcolepsy patients in the year prior to diagnosis by a sleep specialist. Sleep 2002, 25(1):36-41.
16. Morrish E., King M.A., Smith I.E., Shneerson J.M. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med 2004, 5(1):37-41.
17. Dodel R., Peter H., Spottke A., Noelker C., Althaus A., Siebert U., et al. Health-related quality of life in patients with narcolepsy. Sleep Med 2007, 8(7-8):733-741.
18. Campbell A.J., Signal T.L., O'Keeffe K.M., Bakker J.P. Narcolepsy in New Zealand: pathway to diagnosis and effect on quality of life. N Z Med J 2011, 124(1336):51-61.
19. Dauvilliers Y., Bayard S., Shneerson J.M., Plazzi G., Myers A.J., Garcia-Borreguero D. High pain frequency in narcolepsy with cataplexy. Sleep Med 2011, 12(6):572-577.
20. Bayon V., Leger D., Philip P. Socio-professional handicap and accidental risk in patients with hypersomnias of central origin. Sleep Med Rev 2009, 13(6):421-426.
21. Weaver T.E., Cuellar N. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Sleep 2006, 29(9):1189-1194.
22. Ervik S., Abdelnoor M., Heier M.S., Ramberg M., Strand G. Health-related quality of life in narcolepsy. Acta Neurol Scand 2006, 114(3):198-204.
23. Vignatelli L., D'Alessandro R., Mosconi P., Ferini-Strambi L., Guidolin L., De V.A., et al. Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. Sleep Med 2004, 5(5):467-475.
24. Becker P.M., Schwartz J.R., Feldman N.T., Hughes R.J. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology (Berl) 2004, 171(2):133-139.
25. Daniels E., King M.A., Smith I.E., Shneerson J.M. Health-related quality of life in narcolepsy. J Sleep Res 2001, 10(1):75-81.
26. Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology 1998, 50(2 Suppl. 1):S31-S36.
27. Jara C.O., Popp R., Zulley J., Hajak G., Geisler P. Determinants of depressive symptoms in narcoleptic patients with and without cataplexy. J Nerv Ment Dis 2011, 199(5):329-334.
28. O'Brien L.M. The neurocognitive effects of sleep disruption in children and adolescents. Child Adolesc Psychiatr Clin N Am 2009, 18(4):813-823.
29. Dauvilliers Y., Paquereau J., Bastuji H., Drouot X., Weil J.S., Viot-Blanc V. Psychological health in central hypersomnias: the French Harmony study. J Neurol Neurosurg Psychiatry 2009, 80(6):636-641.
30. Jennum P., Wanscher B., Frederiksen J., Kjellberg J. The socioeconomic consequences of multiple sclerosis: a controlled national study. Eur Neuropsychopharmacol 2011.
31. Jennum P., Zoetmulder M., Korbo L., Kjellberg J. The health-related, social, and economic consequences of parkinsonism: a controlled national study. J Neurol 2011, 258(8):1497-1506.
32. Jennum P., Kjellberg J. Health, social and economical consequences of sleep-disordered breathing: a controlled national study. Thorax 2011, 66(7):560-566.
33. Mosbech J., Jorgensen J., Madsen M., Rostgaard K., Thornberg K., Poulsen T.D. The national patient registry. Evaluation of data quality. Ugeskr Laeger 1995, 157(26):3741-3745.